MDXHEALTH SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.77 USD | -2.46% |
|
-3.82% | -29.70% |
| May. 01 | MDxHealth SA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| May. 01 | Transcript : MDxHealth SA, Q1 2024 Earnings Call, May 01, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 69.42 | 74.48 | 143.6 | 0.0153 | 97.41 | 69.62 | - | - |
| Enterprise Value (EV) 2 | 69.42 | 74.48 | 143.6 | 0.0153 | 97.41 | 172.9 | 190.5 | 198.1 |
| P/E ratio | -1.59 x | - | - | - | -2.37 x | -2.75 x | -4.07 x | -7.23 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 6.41 x | 4.87 x | 7.17 x | 0 x | 1.51 x | 0.88 x | 0.78 x | 0.67 x |
| EV / Revenue | 6.41 x | 4.87 x | 7.17 x | 0 x | 1.51 x | 2.2 x | 2.12 x | 1.9 x |
| EV / EBITDA | -2.54 x | -3.78 x | -6.69 x | -0 x | -5.19 x | -14.8 x | -87.3 x | 31.1 x |
| EV / FCF | - | -4.34 x | - | - | -4 x | -10.4 x | -21.2 x | 235 x |
| FCF Yield | - | -23% | - | - | -25% | -9.64% | -4.72% | 0.43% |
| Price to Book | - | - | - | - | - | -3.96 x | -2.1 x | -1.76 x |
| Nbr of stocks (in thousands) | 7,053 | 9,069 | 15,597 | 16,288 | 27,288 | 27,288 | - | - |
| Reference price 3 | 11.00 | 10.10 | 10.40 | 0.001000 | 3.940 | 2.770 | 2.770 | 2.770 |
| Announcement Date | 2/26/20 | 3/3/21 | 3/2/22 | 3/8/23 | 3/6/24 | - | - | - |
1USD in Million2EUR in Million3USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10.83 | 15.29 | 20.05 | 35.07 | 64.39 | 78.66 | 89.78 | 104 |
| EBITDA 1 | -27.28 | -19.71 | -21.46 | -31.23 | -18.78 | -11.71 | -2.182 | 6.362 |
| EBIT 1 | -30.42 | - | -24.2 | -35.87 | -25.07 | -18.35 | -8.736 | -0.3637 |
| Operating Margin | -280.79% | - | -120.69% | -102.28% | -38.93% | -23.33% | -9.73% | -0.35% |
| Earnings before Tax (EBT) 1 | -40.15 | - | - | - | -39.53 | -26.98 | -18.83 | -10.76 |
| Net income 1 | -39.62 | - | -26.15 | -41.69 | -39.54 | -26.12 | -17.87 | -10.04 |
| Net margin | -365.72% | - | -130.41% | -118.86% | -61.4% | -33.2% | -19.91% | -9.66% |
| EPS 2 | -6.900 | - | - | - | -1.660 | -1.006 | -0.6800 | -0.3833 |
| Free Cash Flow 1 | - | -17.16 | - | - | -24.32 | -16.67 | -8.988 | 0.843 |
| FCF margin | - | -112.22% | - | - | -37.78% | -21.19% | -10.01% | 0.81% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 13.25% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/26/20 | 3/3/21 | 3/2/22 | 3/8/23 | 3/6/24 | - | - | - |
1EUR in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 S1 | 2021 Q3 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8.355 | - | 5.075 | 5.793 | 6.926 | 11.15 | 12.2 | 13.52 | 15.43 | 18.07 | 17.79 | 18.55 | 19.22 | 20.14 | 20.81 | 20.85 |
| EBITDA 1 | -9.634 | - | -5.934 | -7.268 | -8.384 | -7.944 | -10.13 | -6.513 | -5.499 | -2.35 | -4.333 | -4.242 | -3.094 | -1.884 | -2.242 | -1.901 |
| EBIT 1 | -10.98 | - | -6.598 | -7.45 | -9.202 | -8.135 | -12.05 | -8.018 | -7.136 | -4.259 | -5.784 | -6.176 | -4.974 | -4.022 | -4.022 | -3.837 |
| Operating Margin | -131.46% | - | -130% | -128.59% | -132.86% | -72.99% | -98.8% | -59.3% | -46.24% | -23.57% | -32.51% | -33.3% | -25.88% | -19.97% | -19.33% | -18.4% |
| Earnings before Tax (EBT) 1 | - | - | - | -7.847 | -9.866 | - | - | -10.77 | -9.793 | -9.38 | -9.833 | -7.959 | -7.254 | -6.38 | -6.381 | -6.195 |
| Net income 1 | - | -11.3 | -7.032 | -7.847 | -9.867 | - | -16.4 | -10.77 | -9.793 | -9.38 | -9.833 | -7.959 | -7.098 | -6.224 | -6.225 | -6.039 |
| Net margin | - | - | -138.55% | -135.44% | -142.46% | - | -134.41% | -79.65% | -63.46% | -51.91% | -55.26% | -42.91% | -36.93% | -30.91% | -29.92% | -28.97% |
| EPS 2 | - | - | - | - | - | - | - | - | - | - | -0.3900 | -0.3100 | -0.2650 | -0.2300 | -0.2275 | -0.2225 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/26/20 | 9/16/21 | 1/20/23 | 4/27/22 | 8/25/22 | 10/27/22 | 3/8/23 | 5/15/23 | 8/23/23 | 11/8/23 | 3/6/24 | 5/1/24 | - | - | - | - |
1EUR in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 103 | 121 | 128 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -8.819 x | -55.38 x | 20.19 x |
| Free Cash Flow 1 | - | -17.2 | - | - | -24.3 | -16.7 | -8.99 | 0.84 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | - | - | - | -0.7000 | -1.320 | -1.570 |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 0.07 | 0.45 | - | - | 4.6 | 5.24 | 4.49 | 3.65 |
| Capex / Sales | 0.62% | 2.92% | - | - | 7.15% | 6.66% | 5.01% | 3.51% |
| Announcement Date | 2/26/20 | 3/3/21 | 3/2/22 | 3/8/23 | 3/6/24 | - | - | - |
1EUR in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.77
USD
Average target price
7.25
USD
Spread / Average Target
+161.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.70% | 77.5M | |
| +44.48% | 54.04B | |
| +43.57% | 41.96B | |
| -0.86% | 41.92B | |
| -7.59% | 28.35B | |
| +12.30% | 26.35B | |
| -21.83% | 19B | |
| +7.15% | 13B | |
| +29.40% | 12.28B | |
| +25.15% | 12.19B |
- Stock Market
- Equities
- MDXH Stock
- Financials MDxHealth SA
